#SARS-CoV-2

Effects of the body’s response to the coronavirus on the brain, spinal cord, nerves and muscle can be particularly devastating.

Plitidepsin, derived from a sea squirt, may be far more potent than remdesivir against the coronavirus.

Long-lived memory immune cells continue to provide protection even after antibody levels drop.

With the vaccine rollout going slowly, experts debate delayed second dose and other strategies.

The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.

The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.

Scientists fear another virus will leap from wildlife into humans, one that is far more lethal but spreads as easily as SARS-CoV-2.

Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.

People who have had evidence of a prior infection appear to have some degree of protection against being reinfected with the virus.

American hubris prevented the country from reacting as quickly and effectively as Asian nations.

Bamlanivimab did not speed clinical improvement or reduce the time to hospital discharge or sustained recovery.

Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.

Anthony Fauci, President-elect Joe Biden and senior legislators were vaccinated publicly to demonstrate their confidence in vaccine safety.

The feat facing public health officials has absolutely no comparison in recent history.

Among 64 pregnant women who tested positive for SARS-CoV-2, none of their newborns tested positive.